AU2017428737B2 - Dynamic human heavy chain antibody libraries - Google Patents

Dynamic human heavy chain antibody libraries Download PDF

Info

Publication number
AU2017428737B2
AU2017428737B2 AU2017428737A AU2017428737A AU2017428737B2 AU 2017428737 B2 AU2017428737 B2 AU 2017428737B2 AU 2017428737 A AU2017428737 A AU 2017428737A AU 2017428737 A AU2017428737 A AU 2017428737A AU 2017428737 B2 AU2017428737 B2 AU 2017428737B2
Authority
AU
Australia
Prior art keywords
hvr
amino acid
acid sequence
seq
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017428737A
Other languages
English (en)
Other versions
AU2017428737A8 (en
AU2017428737A1 (en
Inventor
Fangyong Du
Yan Li
Peter Peizhi Luo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adagene Inc
Original Assignee
Adagene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adagene Inc filed Critical Adagene Inc
Publication of AU2017428737A1 publication Critical patent/AU2017428737A1/en
Publication of AU2017428737A8 publication Critical patent/AU2017428737A8/en
Application granted granted Critical
Publication of AU2017428737B2 publication Critical patent/AU2017428737B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/04—Methods of creating libraries, e.g. combinatorial synthesis using dynamic combinatorial chemistry techniques
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2017428737A 2017-08-21 2017-08-21 Dynamic human heavy chain antibody libraries Active AU2017428737B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/098299 WO2019036842A1 (en) 2017-08-21 2017-08-21 DYNAMIC LIBRARIES OF HUMAN HEAVY CHAIN ANTIBODIES

Publications (3)

Publication Number Publication Date
AU2017428737A1 AU2017428737A1 (en) 2020-03-05
AU2017428737A8 AU2017428737A8 (en) 2020-03-12
AU2017428737B2 true AU2017428737B2 (en) 2024-02-15

Family

ID=65438261

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017428737A Active AU2017428737B2 (en) 2017-08-21 2017-08-21 Dynamic human heavy chain antibody libraries

Country Status (13)

Country Link
US (2) US11578426B2 (https=)
EP (1) EP3673101A4 (https=)
JP (3) JP2020537632A (https=)
KR (2) KR20200038996A (https=)
CN (1) CN111279024B (https=)
AU (1) AU2017428737B2 (https=)
BR (1) BR112020003622A2 (https=)
CA (1) CA3072143A1 (https=)
IL (1) IL272696B2 (https=)
NZ (1) NZ761783A (https=)
SG (1) SG11202001551YA (https=)
WO (1) WO2019036842A1 (https=)
ZA (1) ZA202001114B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019036855A1 (en) 2017-08-21 2019-02-28 Adagene Inc. Anti-cd137 molecules and use thereof
NZ761785A (en) 2017-08-21 2025-11-28 Adagene Inc Dynamic human antibody light chain libraries
IL272696B2 (en) 2017-08-21 2025-01-01 Adagene Inc Dynamic human heavy chain antibody libraries
WO2019148445A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Precision/context-dependent activatable antibodies, and methods of making and using the same
WO2019148444A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Anti-ctla4 antibodies and methods of making and using the same
CN113966230B (zh) * 2019-12-24 2022-06-07 宝船生物医药科技(上海)有限公司 抗csf1r分子及其用途
JP2023529557A (ja) 2020-05-04 2023-07-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗ｅｎｐｐ１抗体の阻害
US20230374162A1 (en) * 2020-10-07 2023-11-23 Amgen Inc. Rational selection of building blocks for the assembly of multispecific antibodies
WO2023193239A1 (en) * 2022-04-08 2023-10-12 Peter Peizhi Luo Anti-cd28 antibodies and methods of use thereof
KR20260026665A (ko) 2024-08-20 2026-02-27 엘지디스플레이 주식회사 표시 장치

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440146A2 (de) * 1990-02-01 1991-08-07 BEHRINGWERKE Aktiengesellschaft Herstellung und Verwendung von Genbanken synthetischer menschlicher Antikörper ("synthetische Human-Anti-Körper-Bibliotheken)
EP1457559A1 (en) * 2001-11-22 2004-09-15 Keio University ARTIFICIAL ANTIBODY LIBRARY WITH SUPER−REPERTORY
WO2012009568A2 (en) * 2010-07-16 2012-01-19 Adimab, Llc Antibody libraries
WO2012023053A2 (en) * 2010-08-16 2012-02-23 Novimmune S.A. Methods for the generation of multispecific and multivalent antibodies
WO2016062989A1 (en) * 2014-10-22 2016-04-28 Crescendo Biologics Limited Human vh domain scaffolds

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
DE69120146T2 (de) 1990-01-12 1996-12-12 Cell Genesys Inc Erzeugung xenogener antikörper
WO1996033735A1 (en) 1995-04-27 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5866344A (en) 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
US20030036092A1 (en) 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
ES2248127T3 (es) 1999-10-04 2006-03-16 Medicago Inc. Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno.
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
WO2006120230A2 (en) 2005-05-12 2006-11-16 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
ES2577292T3 (es) 2005-11-07 2016-07-14 Genentech, Inc. Polipéptidos de unión con secuencias hipervariables de VH/VL diversificadas y consenso
EP2604279A1 (en) 2008-03-27 2013-06-19 ZymoGenetics, Inc. Compositions and methods for inhibiting PDGFRBETA and VEGF-A
CN105247050B (zh) 2013-03-14 2020-06-16 天演药业 用于文库构建、亲和力结合剂筛选和其表达的整合系统
CN103603057B (zh) 2013-07-03 2016-01-06 深圳大学 基于可感染病毒颗粒型抗体重链库/轻链库的抗体筛选和制备方法
CA3289997A1 (en) 2015-09-20 2026-03-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Monoclonal Antibodies Specific for Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods of Their Use
IL272696B2 (en) 2017-08-21 2025-01-01 Adagene Inc Dynamic human heavy chain antibody libraries
NZ761785A (en) 2017-08-21 2025-11-28 Adagene Inc Dynamic human antibody light chain libraries

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0440146A2 (de) * 1990-02-01 1991-08-07 BEHRINGWERKE Aktiengesellschaft Herstellung und Verwendung von Genbanken synthetischer menschlicher Antikörper ("synthetische Human-Anti-Körper-Bibliotheken)
EP1457559A1 (en) * 2001-11-22 2004-09-15 Keio University ARTIFICIAL ANTIBODY LIBRARY WITH SUPER−REPERTORY
WO2012009568A2 (en) * 2010-07-16 2012-01-19 Adimab, Llc Antibody libraries
WO2012023053A2 (en) * 2010-08-16 2012-02-23 Novimmune S.A. Methods for the generation of multispecific and multivalent antibodies
WO2016062989A1 (en) * 2014-10-22 2016-04-28 Crescendo Biologics Limited Human vh domain scaffolds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEN W ET AL, JOURNAL OF MOLECULAR BIOLOGY, vol. 382, no. 3, 10 October 2008, pages 779 - 789 *
CHEN WEIZAO ET AL: "Construction of a Human Antibody Domain (V-H) Library", ANTIBODY-DRUG CONJUGATES; IN: METHODS IN MOLECULAR BIOLOGY; VOL. 263; [METHODS IN MOLECULAR BIOLOGY; ISSN 1064-3745], vol. 525, 1 January 2009, pages 81 - 99 *
LEE C V ET AL: "High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework Scaffold", JOURNAL OF MOLECULAR BIOLOGY, vol. 340, no. 5, 23 July 2004, pages 1073 - 1093 *
SIDHU S S ET AL: "Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions", JOURNAL OF MOLECULAR BIOLOGY, vol. 338, no. 2, 23 April 2004, pages 299 - 310 *

Also Published As

Publication number Publication date
BR112020003622A2 (pt) 2020-09-01
CA3072143A1 (en) 2019-02-28
KR102907590B1 (ko) 2026-01-05
IL272696A (en) 2020-04-30
US20200248336A1 (en) 2020-08-06
AU2017428737A8 (en) 2020-03-12
JP2024178314A (ja) 2024-12-24
EP3673101A4 (en) 2021-03-24
AU2017428737A1 (en) 2020-03-05
WO2019036842A1 (en) 2019-02-28
EP3673101A1 (en) 2020-07-01
US20240240358A1 (en) 2024-07-18
CN111279024B (zh) 2024-07-19
US12385162B2 (en) 2025-08-12
IL272696B2 (en) 2025-01-01
ZA202001114B (en) 2024-06-26
IL272696B1 (en) 2024-09-01
SG11202001551YA (en) 2020-03-30
NZ761783A (en) 2025-11-28
KR20240110891A (ko) 2024-07-16
JP2020537632A (ja) 2020-12-24
KR20200038996A (ko) 2020-04-14
CN111279024A (zh) 2020-06-12
US11578426B2 (en) 2023-02-14
JP2023025026A (ja) 2023-02-21

Similar Documents

Publication Publication Date Title
AU2017428737B2 (en) Dynamic human heavy chain antibody libraries
US20230287597A1 (en) Dynamic human antibody light chain libraries
CA2572917C (en) Look-through mutagenesis for developing altered polypeptides with enhanced properties
CA2823044C (en) Express humanization of antibodies
EP2513312B1 (en) Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
KR101796689B1 (ko) 안정화된 면역글로불린가변도메인 선별방법 및 선별된 도메인의 응용
JP6309518B2 (ja) 発現及び分泌システム
CN113195537A (zh) 抗体文库及方法
JP2020534796A (ja) エピトープ翻訳後修飾状態に特異的な抗体の開発方法及び開発のための組成物
KR20260011157A (ko) 항체 점도를 낮추는 방법 및 조성물
Vellalore Maruthachalam NEXT-GENERATION SEQUENCING AND MOTIF GRAFTING APPLICATIONS IN SYNTHETIC ANTIBODY DISCOVERY
HK40051447A (en) Screening and engineering method of super-stable immunoglobulin variable domains and their uses

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 34 , NO 9 , PAGE(S) 1349 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME ADAGENE INC., APPLICATION NO. 2017428737, UNDER INID (72) ADD CO-INVENTOR LUO, PETER PEIZHI

FGA Letters patent sealed or granted (standard patent)